NYSE$SLQT
Selectquote Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
SelectQuote's Q2 2024 results were reported, showing increased revenue and net income.
SelectQuote reported a strong second quarter with revenue of $405.4 million and net income of $19.4 million. The company is raising its fiscal year 2024 guidance, expecting revenue between $1.23 billion and $1.3 billion and adjusted EBITDA between $90 million and $105 million.
- SelectQuote's second quarter marked the eighth consecutive quarter of performance ahead of expectations.
- The company's Senior business grew revenues by double digits, with an Adjusted EBITDA margin of 32%.
- Healthcare Services, particularly SelectRx, drove substantial growth, exceeding original forecasts with over 62,000 members.
- SelectQuote anticipates approaching positive free cash flow in fiscal year 2024.
Headline financials
Revenue & EPS history
SelectQuote · Revenue · Quarterly
$405M
Revenue by segment
SelectQuote · $128M total across 2 segments · Q1 2024
- Senior$89.9M+16.0%70.4%
- Life$37.8M+2.7%29.6%
Forward guidance
SelectQuote is raising its fiscal year 2024 guidance ranges.
Tailwinds
- Revenue expected in a range of $1.23 billion to $1.3 billion (previous $1.05 billion to $1.2 billion).
- Net loss expected in a range of $45 million to $22 million (previous $50 million to $22 million).
- Adjusted EBITDA expected in a range of $90 million to $105 million (previous $80 million to $105 million).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-2.4%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+2.2%
Avg return
30 days after
57%
17 / 30 earnings
Positive
+75.5%
Q2 2023
Best reaction
-49.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -8.9% | +39.9% | +24.3% | |
| Q2 2026 | -29.0% | -37.4% | -47.9% | |
| Q1 2026 | +0.0% | -16.8% | -29.3% | |
| Q3 2025 | -12.1% | -14.2% | -15.4% | |
| Q2 2025 | +30.8% | +37.0% | -17.4% | |
| Q1 2025 | +6.9% | +16.7% | +46.1% | |
| Q4 2024 | -49.0% | -44.6% | -37.6% | |
| Q3 2024 | +4.8% | +12.4% | +13.2% | |
| Q2 2024 | +6.3% | +40.5% | +64.0% | |
| Q1 2024 | -4.3% | -5.8% | -3.6% | |
| Q4 2023 | -16.2% | -16.9% | -8.8% | |
| Q3 2023 | +11.1% | -16.7% | +16.7% | |
| Q2 2023 | +75.5% | +128.8% | +181.1% | |
| Q1 2023 | +9.5% | +9.2% | +17.7% | |
| Q4 2022 | -30.4% | -47.5% | -54.9% | |
| Q3 2022 | +7.5% | +0.4% | +20.4% | |
| Q2 2022 | -48.0% | -55.4% | -60.1% | |
| Q1 2022 | -22.3% | -17.8% | -36.3% | |
| Q4 2021 | -44.6% | -37.6% | -7.2% | |
| Q3 2020 | -21.5% | -22.2% | -23.4% | |
| Q3 2021 | -21.9% | -23.2% | -26.6% | |
| Q2 2020 | +7.7% | +9.2% | +7.4% | |
| Q2 2021 | +7.7% | +9.2% | +7.4% | |
| Q1 2020 | +2.7% | +7.7% | +20.3% | |
| Q1 2021 | +7.6% | +10.5% | +23.0% | |
| Q4 2018 | +10.9% | +12.0% | -2.1% | |
| Q4 2019 | +10.9% | +12.0% | -2.1% | |
| Q3 2019 | +10.9% | +12.0% | -2.1% | |
| Q2 2019 | +10.9% | +12.0% | -2.1% | |
| Q4 2020 | +14.2% | +20.1% | +0.3% | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro